Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cesca Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

Cesca Therapeutics

30 Apr 2016 S&P Capital IQ Quantitative Report 10 $115.00

THERMOGENESIS CORP (KOOL=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

30 Apr 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Cesca Therapeutics Inc (KOOL-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 12 $25.00

Wright Investors Service Comprehensive Report for Cesca Therapeutics Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Apr 2016 Wright Reports 54 $75.00

KOOL: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

29 Apr 2016 New Constructs, LLC 10 $25.00

Value Graph: CESCA THERAPEUT -- KOOL

29 Apr 2016 Ford Investor Services, Inc. 1 $12.00

Cesca Therapeutics Inc: Downgraded to Risky

07 Apr 2016 Sadif Analytics Prime 3 $10.00

Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review

Cesca Therapeutics Inc. (KOOL) - Financial and Strategic SWOT Analysis Review Summary Cesca Therapeutics Inc. (Cesca) formerl...

05 Apr 2016 GlobalData 92 $300.00

Interview with the Director, President & CEO: Cesca Therapeutics, Inc. (NASDAQ:KOOL)

17 Mar 2016 Wall Street Transcript ,The 5 $50.00